A detailed history of Sterling Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 471,113 shares of ABBV stock, worth $95.2 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
471,113
Previous 724,647 34.99%
Holding current value
$95.2 Million
Previous $143 Billion 41.5%
% of portfolio
1.15%
Previous 1.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$164.99 - $203.87 $41.8 Million - $51.7 Million
-253,534 Reduced 34.99%
471,113 $83.7 Billion
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $94.5 Million - $115 Million
-576,552 Reduced 44.31%
724,647 $143 Billion
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $81.9 Million - $98.5 Million
1,301,199 New
1,301,199 $98.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.